FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/098126 [Registered on: 26/11/2025] Trial Registered Prospectively
Last Modified On: 25/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   How Glaucoma Eye Drops Affect Eye Surface Health And Comfort 
Scientific Title of Study   Prevalence And Patterns of Ocular Surface Disease Among Glaucoma Patients On Topical Medications 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sajjanshetty Vivek 
Designation  Post Graduate Student 
Affiliation  Datta Meghe Institute Of Higher Education And Research 
Address  Department Of Ophthalmology,Ground Floor,Avbrh Building,Sawangi (Meghe) Wardha Maharashtra
Department Of Ophthalmology,Ground Floor,Avbrh Building,Sawangi (Meghe) Wardha Maharashtra
Wardha
MAHARASHTRA
442001
India 
Phone  9380877209  
Fax    
Email  sajjanshettyvivek646@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shashank Banait 
Designation  Associate Professor 
Affiliation  Datta Meghe Institute Of Higher Education And Research 
Address  Department Of Ophthalmology,Ground Floor,Avbrh Building,Sawangi (Meghe) Wardha Maharashtra
Department Of Ophthalmology,Ground Floor,Avbrh Building,Sawangi (Meghe) Wardha Maharashtra
Wardha
MAHARASHTRA
442001
India 
Phone  9822226124  
Fax    
Email  shashankbanait@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Shashank Banait 
Designation  Associate Professor 
Affiliation  Datta Meghe Institute Of Higher Education And Research 
Address  Department Of Ophthalmology,Ground Floor,Avbrh Building,Sawangi (Meghe) Wardha Maharashtra
Department Of Ophthalmology,Ground Floor,Avbrh Building,Sawangi (Meghe) Wardha Maharashtra
Wardha
MAHARASHTRA
442001
India 
Phone  9822226124  
Fax    
Email  shashankbanait@yahoo.co.in  
 
Source of Monetary or Material Support  
Datta Meghe Institute Of Higher Education And Research Sawangi Meghe Wardha,Maharashtra India 442001 
 
Primary Sponsor  
Name  Datta Meghe Institute Of Higher Education And Research 
Address  Sawangi Meghe Wardha,India 442001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sajjanshetty Vivek  Acharya Vinoba Bhave Rural Hospital  Room No-24 Department Of Ophthalmology,Ground Floor,Avbrh Building A Block,Sawangi (Meghe) Wardha Maharashtra India 442001
Wardha
MAHARASHTRA 
9380877209

sajjanshettyvivek646@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE DMIHER  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H409||Unspecified glaucoma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  40.00 Day(s)
Age To  99.00 Day(s)
Gender  Both 
Details  DIAGNOSED CASES OF GLAUCOMA (PRIMARY OPEN ANGLE, ANGLE CLOSURE,
PSEUDOEXFOLIATION, PIGMENTARY GLAUCOMA)

ON TOPICAL ANTIGLAUCOMA MEDICATIONS FOR MORE THAN 6 MONTHS

WILLINGNESS TO PROVIDE WRITTEN INFORMED CONSENT.

SUBJECTS NOT USING ANY TOPICAL OCULAR MEDICATIONS
 
 
ExclusionCriteria 
Details  USE OF TOPICAL STEROIDS OR LUBRICANTS

HISTORY OF OCULAR SURGERY

SECONDARY GLAUCOMA (E.G., UVEITIC, LENS-INDUCED)

CONTACT LENS USERS

KNOWN SYSTEMIC DISEASES AFFECTING TEAR FILM (E.G., SJOGRENS SYNDROME) 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
TO IDENTIFY CLINICAL AND DEMOGRAPHIC RISK FACTORS (E.G., AGE,
COMORBIDITIES, POLYPHARMACY) ASSOCIATED WITH OCULAR SURFACE DISEASES IN GLAUCOMA
PATIENTS. 
1ST DAY & 15TH DAY 
 
Secondary Outcome  
Outcome  TimePoints 
TO DETERMINE THE PREVALENCE AND SEVERITY OF OSD IN GLAUCOMA
PATIENTS (EG- USING OSDI (OCULAR SURFACE DISEASES INDEX), TBUT(TEAR BREAKUP TIME), SCHIRMER’S TEST, AND LISSAMINE
GREEN STAINING).

TO COMPARE THESE FINDINGS WITH HEALTHY CONTROLS.

TO ASSESS THE CORRELATION BETWEEN OSD (OCULAR SURFACE DISEASES) SEVERITY AND
NUMBER/DURATION OF ANTIGLAUCOMA MEDICATIONS.

TO ASSESS THE IMPACT OF PRESERVATIVE-CONTAINING VERSUS
PRESERVATIVE-FREE FORMULATIONS ON OCULAR SURFACE PARAMETERS.

TO EXPLORE TREATMENT PATTERNS AND GAPS IN THE CURRENT MANAGEMENT
OF OSD IN GLAUCOMA 
1ST & 15TH DAY 
 
Target Sample Size   Total Sample Size="98"
Sample Size from India="98" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   13/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

THIS STUDY AIMS TO DETERMINE HOW COMMON OCULAR SURFACE DISEASE IS AMONG GLAUCOMA PATIENTS WHO USE TOPICAL ANTIGLAUCOMA MEDICATIONS AND TO IDENTIFY THE PATTERNS AND RISK FACTORS ASSOCIATED WITH IT. LONG TERM USE OF GLAUCOMA EYE DROPS, ESPECIALLY THOSE CONTAINING PRESERVATIVES, CAN CAUSE DRYNESS, IRRITATION, TEAR FILM INSTABILITY, AND SURFACE DAMAGE. THE STUDY WILL INCLUDE 98 PARTICIPANTS, DIVIDED INTO A STUDY GROUP OF GLAUCOMA PATIENTS ON TOPICAL THERAPY AND A CONTROL GROUP WITHOUT ANY TOPICAL EYE MEDICATION USE. EACH PARTICIPANT WILL UNDERGO A STRUCTURED ASSESSMENT THAT INCLUDES OSDI QUESTIONNAIRE, TEAR BREAKUP TIME, SCHIRMER TEST, AND OCULAR SURFACE STAINING. DEMOGRAPHIC DATA, TYPE AND NUMBER OF MEDICATIONS, DURATION OF TREATMENT, AND PRESERVATIVE EXPOSURE WILL ALSO BE RECORDED. THE RESULTS WILL HELP ESTIMATE THE PREVALENCE AND SEVERITY OF OCULAR SURFACE DISEASE IN THIS POPULATION AND IDENTIFY ASSOCIATIONS WITH MEDICATION BURDEN AND PRESERVATIVE USE. FINDINGS ARE EXPECTED TO GUIDE BETTER SCREENING AND MANAGEMENT PRACTICES FOR OCULAR SURFACE PROBLEMS IN GLAUCOMA PATIENTS.

 

 
Close